Overview

Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The treatment of acute pain in patients with irritable bowel symptoms is suboptimal. This is a placebo controlled study of the on demand treatment of pain experienced over a 4 week period in patients with irritable bowel syndrome. Patients will record the severity of pain when they take the study medication and two hours later.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic